Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The ongoing evolution of dendritic cell therapy

M H Sokoloff, N Vogelzang

    Cancer
    |December 14, 1999
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinoma.

    Annals of oncology : official journal of the European Society for Medical Oncology·2017
    Same author

    Cabozantinib in hepatocellular carcinoma: results of a phase 2 placebo-controlled randomized discontinuation study.

    Annals of oncology : official journal of the European Society for Medical Oncology·2017
    Same author

    A Phase II trial of a combination herbal supplement for men with biochemically recurrent prostate cancer.

    Prostate cancer and prostatic diseases·2014
    Same author

    Immunotherapy and gene therapy for genitourinary malignancies.

    International journal of urology : official journal of the Japanese Urological Association·2013
    Same author

    Phase-I trial of Thiotepa, granulocyte-macrophage colony-stimulating factor and prednisone or pentoxifylline in patients with refractory solid tumors.

    Oncology reports·2011
    Same author

    Phase-ii evaluation of single-agent Carboplatin in advanced thyroid-carcinoma.

    Oncology reports·2011